GW Pharmaceuticals PLC GWPH, -4.44% said Monday it has received European Commission approval for its cannabis -based drug Epidyolex for the … Read More
The post GW Pharma gets EU approval for cannabis -based drug as treatment for severe childhood epilepsy appeared first on Dagga Magazine.